Cambridge Cluster Investor Raises £75m To Fund UK Startups
Executive Summary
Cambridge Innovation Capital, an investment firm focused on the University of Cambridge and the "Cambridge Cluster", has raised £75m for its healthcare fund in order to pursue new opportunities and expand its staff – a move highlighted as promising for the life sciences sector in the aftermath of Brexit.
You may also be interested in...
Sanger Institute Spin-Out Microbiotica To Evaluate Bacterial Mixes
The UK Wellcome Trust Sanger Institute’s latest spin-out has received start-up funding to exploit more than six years of gut bacterial genome sequencing in order to develop novel bacteria-based therapies for a range of diseases.
Snapshot: April Highlights
A selection of articles you might have missed from April 2022, including exclusive interviews, an in depth look at the impact of COVID-19 on clinical trial trends, and the latest Rising Leaders series.
Transforming Patient Engagement At Novartis
Rising Leader Yolanda Tibbe, Novartis’s head of new commercial partnerships in Germany, talks about transformation at the Swiss big pharma and how to put ‘patients as customers’ thinking into action.